.Three weeks after Roche's Genentech device walked away from an SHP2 prevention deal, Relay Therapy ...
.Stoke Therapies' Dravet disorder medicine has been without a partial hold, removing the way for the...
.Brutal Biotech Associate Publisher Gabrielle Masson showed the 2024 class of Ferocious 15 victors o...
.Novo Nordisk has axed its own once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) advance...
.Merck & Co. has swiftly redeemed some of the expenses of its own Weapon Rehabs buyout, pulling i...
.After BioMarin administered a spring season tidy of its own pipeline in April, the firm has actuall...
.Huge Pharmas remain stuck to the suggestion of molecular adhesive degraders. The most up to date fi...
.A new worldwide life scientific research credit scores company, nicknamed Symbiotic Funding, has ac...
.Bristol Myers Squibb is actually axing an additional huge bet from the Caforio age, ending a deal f...
.After checking out at stage 1 record, Nuvation Bio has made a decision to halt focus on its own sin...